Originally published In Press as doi:10.1074/jbc.M201999200 on March 20, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21130-21139, June 14, 2002
L-selectin Dimerization Enhances Tether Formation to Properly
Spaced Ligand*
Oren
Dwir
,
Douglas A.
Steeber§,
Ulrich S.
Schwarz¶
,
Raymond T.
Camphausen**,
Geoffrey S.
Kansas
§§,
Thomas F.
Tedder§, and
Ronen
Alon
¶¶
From the
Department of Immunology, Weizmann Institute
of Science, Rehovot, 76100 Israel, the § Department of
Immunology, Duke University Medical Center, Durham, North Carolina
27710, ¶ Max-Planck-Institute of Colloids and Interfaces,
Potsdam, Germany 14424, ** Wyeth/Genetics Institute,
Cambridge, Massachusetts 02140, and the

Department of Microbiology-Immunology,
Northwestern Medical School, Chicago, Illinois 60611
Received for publication, February 28, 2002
 |
ABSTRACT |
Selectin counterreceptors are glycoprotein
scaffolds bearing multiple carbohydrate ligands with exceptional
ability to tether flowing cells under disruptive shear forces. Bond
clusters may facilitate formation and stabilization of selectin
tethers. L-selectin ligation has been shown to enhance L-selectin
rolling on endothelial surfaces. We now report that monoclonal
antibodies-induced L-selectin dimerization enhances L-selectin
leukocyte tethering to purified physiological L-selectin ligands and
glycopeptides. Microkinetic analysis of individual tethers suggests
that leukocyte rolling is enhanced through the dimerization-induced
increase in tether formation, rather than by tether stabilization.
Notably, L-selectin dimerization failed to augment L-selectin-mediated
adhesion below a threshold ligand density, suggesting that L-selectin
dimerization enhanced adhesiveness only to properly clustered ligand.
In contrast, an epidermal growth factor domain substitution of
L-selectin enhanced tether formation to L-selectin ligands irrespective
of ligand density, suggesting that this domain controls intrinsic
ligand binding properties of L-selectin without inducing L-selectin
dimerization. Strikingly, at low ligand densities, where L-selectin
tethering was not responsive to dimerization, elevated shear stress
restored sensitivity of tethering to selectin dimerization. This is the first indication that shear stress augments effective selectin ligand
density at local contact sites by promoting L-selectin encounter of
immobilized ligand.
 |
INTRODUCTION |
Selectins are specialized C-type lectins that mediate the
reversible capture (tethering) of circulating cell subsets to specific vessel walls and its subsequent rolling tethers in the direction of
flow (1, 2). The biophysical basis for the exceptional ability of
selectins to mediate cell capture (tethering) and rolling adhesions
under highly disruptive forces is still obscure (3-6). This ability
has been primarily attributed to fast formation rates of selectin bonds
and to the ability of selectin tethers to tolerate rupture by elevated
shear forces (7-10). A major unresolved question regarding selectin
function is the high effective formation rate of selectin tethers to
their physiological counterreceptors. Efficient tether formation, in
particular by L-selectin, contrasts with the fairly low
kon of intrinsic L-selectin bonds (11). This kon falls in a range shared by other molecular
pairs with poor tethering capacity under shear flow (12, 13). It has
thus become increasingly evident that selectin tethering to ligand is
controlled by mechanical properties in addition to the biochemical properties measured under shear-free conditions (14, 15).
In addition to the fast effective kinetics of bond formation and
intrinsically high mechanical stability of individual bonds (5), three
other mechanisms have been proposed to account for the exceptionally
high capacity of selectins to form tethers under physiological flow.
Association of L-selectin with the actin cytoskeleton through its
cytoplasmic domain was recently shown to reduce tether dissociation
rates under flow and to enhance the mechanical stability of selectin
tethers, independent of the intrinsic stability of the selectin:ligand
bond (16). This stabilization was suggested to involve tail-mediated
restriction of the selectin's mobility at the membrane, which
facilitates its rebinding to a recently dissociated ligand on a
countersurface (16). In addition, a regulatory role for the
EGF1 domain has been recently
suggested to explain the efficiency by which the lectin domain of
cell-based or cell-free L-selectin recognizes surface-bound ligand
(15). Recent studies also demonstrated that dimerization of L-selectin
or P-selectin, as well as the selectin ligand, PSGL-1, augments
selectin-mediated rolling in different cellular systems (10, 17-19).
The generation of multimeric binding by receptor oligomerization may
provide a rapid means for dispersion of highly disruptive shear forces
over multiple bonds. A role for selectin or ligand clustering in
promoting cell adhesion under flow is feasible because all known
physiological selectin ligands present multiple carbohydrate ligands on
mucin-like scaffolds or on complex multivalent glycans (2, 20, 21). Selectins are also often found clustered on leukocyte surfaces (18, 22)
although the contribution of spontaneous L-selectin clustering to the
selectin adhesiveness under physiological shear flow has not been established.
In the present study, we assessed the effect of L-selectin
dimerization on its adhesiveness to various purified L-selectin ligands
and under various conditions of shear flow. The extensive data
previously obtained on both the biochemical nature and clustering properties of PSGL-1 and its individual selectin-binding carbohydrates and backbone residues (19, 23, 24) render this ligand an ideal model to
assess how L-selectin dimerization and ligand presentation affect
specific kinetic properties of selectin tethers under defined flow
conditions. We therefore focused our study on native neutrophil-derived PSGL-1 as well as on synthetically generated PSGL-1-derived
glycopeptides (25). Unexpectedly, dimerization of L-selectin was found
to alter entirely different properties of L-selectin tethers to PSGL-1 than those previously reported for P-selectin dimerization (10). L-selectin dimerization enhanced the tether formation rate without altering tether stability and did so only on ligands presented on an
adhesive surface at densities above a critical threshold. Notably,
increased shear stresses endowed dimerized L-selectin with the ability
to increase its avidity even to highly diluted ligands. Thus, selectin
dimerization results in enhanced avidity and tether formation
conditional to proper ligand spacing and adequate conditions of shear
flow. In contrast to dimerization, EGF domain substitution on
L-selectin with a P-selectin EGF domain enhances tether formation
regardless of ligand density or shear flow, suggesting that this domain
controls intrinsic rather than dimerization properties of
L-selectin.
 |
EXPERIMENTAL PROCEDURES |
Antibodies, Reagents, and Selectin Transfectants
The function-blocking anti-L-selectin mAb, DREG-200 (26), the
anti L-selectin mAbs, LAM1-101 and LAM1-118 (both directed against
the SCR domain of L-selectin) (27), and the anti-PSGL-1 mAb, PL-1 (28),
were used as purified Ig. Full-length PSGL-1, purified from human
neutrophils as previously described (29), a generous gift from Dr.
R. P. McEver (University of Oklahoma, Oklahoma City, OK), was stored
at 4 °C in 1% n-octyl
-D-glucopyranoside/PBS (octyl
glucoside) solution until use. GlyCAM-1, purified from mouse serum by
immunoaffinity chromatography (30), a generous gift from Dr. S. D.
Rosen (University of California, San Francisco, CA), was stored in PBS.
Biotin-labeled PSGL-1-derived sLex-decorated glycopeptide
and a non-fucosylated control peptide, both corresponding to the
19-residue N' terminus of human PSGL-1, and each containing a
single biotin group at its C' terminus, were synthesized as previously
described (25). Neutralite avidin (31) was a gift from Dr. E. A.
Bayer, (Weizmann Institute of Science, Rehovot, Israel). Fucoidin, a
plant-derived sulfated polyfucan that saturably blocks the lectin
domains of L-selectin and P-selectin (32), bovine serum albumin
(fraction V), and Ca2+- and Mg2+-free Hank's
balanced salt solution, were obtained from Sigma. Human serum
albumin, HSA (Fraction V) was obtained from Calbiochem (La Jolla, CA).
The stable expression of cDNA-encoding native human L-selectin or
the L-selectin chimera, LPL, in which the EGF-like domain of L-selectin
was replaced with the homologous domain from P-selectin in the mouse
pre-B cell line 300.19 has been described elsewhere (33). Clones
expressing similar levels of native L-selectin and LPL were maintained
in RPMI 1640, supplemented with 10% fetal calf serum, 2 mM
glutamine, 0.1 µM 2-mercaptoethanol and antibiotics.
Preparation of Ligand-containing Substrates
PSGL-1 was diluted to concentrations of 0.001-0.2 µg/ml in
coating medium (PBS supplemented with 20 mM bicarbonate, pH
8.5) and adsorbed onto a polystyrene plate for 15 h at 4 °C.
Stock solutions of GlyCAM-1, fucoidin, or DREG-200 were diluted
in coating medium and adsorbed onto the plates at 37 °C for 2 h. All substrates were washed five times with PBS and blocked with PBS
supplemented with 2% HSA for 2 h at 4 °C. The site density of
the L-selectin recognition sites on immobilized PSGL-1 was determined
by radioimmunoassay using 125I-labeled PL1 mAb performed as
described (15). GlyCAM-1 site densities were assessed using
125I-labeled CAM02 as described (15). Site densities were
determined for PSGL-1 and GlyCAM-1 coated at input concentrations
>0.05 µg/ml. Below this value, the site densities of both ligands
were estimated from a linear regression of mAb binding to substrates
coated with these mucins at concentrations between 0.05 and 0.2 µg/ml. PSGL-1-derived glycopeptides were immobilized on substrates
coated with a nonglycosylated form of avidin, neutralite avidin (31).
Neutralite avidin was diluted in PBS supplemented with 40 mM bicarbonate, pH 9.0, and immediately adsorbed onto a
polystyrene plate for 15 h at 4 °C, then washed five times with
PBS, and blocked with PBS supplemented with 2% HSA for 2 h at
4 °C. The PSGL-1-derived peptides monobiotinylated in their
C' termini, were each diluted in cell binding medium (see below)
and adsorbed for 4 h on the avidin-coated plate.
Laminar Flow Assays
Cell Treatments--
For cell inhibition studies, selectin
transfectants were incubated in H/H medium (Hank's balanced salt
solution/10 mM HEPES, pH = 7.4, supplemented with 2 mg/ml bovine serum albumin) in the presence of 10 µg/ml of the
L-selectin-blocking mAb, DREG-200, 50 µg/ml fucoidin, or 5 mM EGTA. To induce L-selectin dimerization, cells (2 × 106/ml) were preincubated for 15 min at 25 °C in cell
binding medium (H/H medium supplemented with 2 mM
Ca2+) containing 10 µg/ml of either the
L-selectin-dimerizing mAb, LAM1-118, or the control mAb, LAM1-101
(27). Cells were perfused unwashed over the test substrates. These
conditions were found to induce optimal L-selectin dimerization on
various ligand systems; further cross-linking of the dimerizing mAb had
no additional augmenting effects (data not shown).
Cell Tethering and Rolling Measurements--
The polystyrene
plate, on which purified ligand was adsorbed, was assembled in a
parallel plate laminar flow chamber (260-µm gap) as previously
described (15, 34). Transfected cells were washed in H/H medium at
107 cells/ml, resuspended in binding medium at 2 × 106 cells/ml, and perfused at room temperature through the
flow chamber at desired flow rates, generated using an automated
syringe pump (Harvard Apparatus, Natick, MA). Cellular interactions
were visualized at two different fields of view (each 0.17 mm2 in area) using the 10× objective of an inverted phase
contrast microscope (Diaphot 300, Nikon Inc.). Cell images were
videotaped as previously described (15, 34). When not otherwise
indicated, cell images were manually quantitated by analysis of images
directly from the monitor screen. Two types of initial cell tethering
to the substrate were determined: transient tethers, in which cells attached briefly to the substrate without initiating rolling motions, or stable tethers, in which tethered cells established rolling on the
substrate for at least 3 s after initial tethering. The number of
either transient or rolling-associated tethers was divided by the flux
of freely flowing cells moving through the same field (15). Cell
accumulation assays were performed on cells allowed to settle onto the
substrate for 30 s. The wall shear stress was then increased
stepwise every 5 s. The number of cells accumulated at the end of
each 5 s interval of increased shear and their rolling velocities
were determined by computerized image analysis (see below).
Computerized Microkinetic Analysis
The imaging system developed for quantitative analysis of
instantaneous velocities of cell movement, WSCAN-Array-3 (Galai, Migdal-Ha'emek, Israel), was described elsewhere (15). In summary, individual transfectants rolling on a PSGL-1 coated substrate were
tracked during their movement through the field of view for 3 s at
0.02 s resolution, and the mean displacement velocities of total
cells were derived. Two categories of cells were identified based on
their mean velocity above or below a critical velocity value: cells
moving at a mean velocity <0.25 that of the hydrodynamic velocity
(i.e. of freely moving cells) but above a defined velocity threshold were referred to as jerkily rolling cells; cells moving below
the velocity threshold were defined as smoothly rolling cells.
Microkinetics of individual cells exhibiting jerky rolling was analyzed
on video segments recorded with a high speed camera (500 frames/sec;
Kodak Motion Corder Analyzer, FASTCAM-SUPER 500, Eastman Kodak Co.).
Cell position analysis was preformed at 0.002-s intervals with the
WSCAN-Array-3 software as described (16). At a shear stress of 1 dyn/cm2, specific pauses were defined as cell displacements
of <0.6 µm during a period of 0.006 s separated by cell
displacements of at least 3 µm during 0.004-s periods before and
after each pause. The number of L-selectin-specific pauses per jerky
rolling cell was derived, and the mean number of pauses per cell was
calculated for cell populations of at least 45 cells. The natural log
of the number of pauses with a given duration after pause initiation was plotted against pause duration (16). A first-order dissociation plot yielded a straight line with the slope =
koff.
 |
RESULTS |
Dimerization of L-selectin and EGF Domain Substitution Augments
Adhesiveness to PSGL-1 by Different Mechanisms--
To dimerize
L-selectin while retaining its native cytoskeletal associations,
dimerization of L-selectin was induced by ligation of a site on the SCR
remote from the ligand recognition site (17) using the
L-selectin-dimerizing mAb, LAM-1-118. This mAb was recently shown to
augment L-selectin-mediated rolling to a similar degree as that induced
by cytoplasmic tail-mediated dimerization (17). This study demonstrated
the augmented adhesiveness of mAb-dimerized L-selectin toward
endothelial surfaces expressing L-selectin ligands (17). We therefore
first characterized the effect of L-selectin dimerization on L-selectin
adhesiveness to a purified PSGL-1 homodimer. Consistent with the
previous study, artificial L-selectin dimerization by the dimerizing
mAb augmented L-selectin-dependent capture and rolling of
L-selectin transfected 300.19 pre-B cells on purified high density
PSGL-1 under optimal dimerizing conditions (Fig. 1A), whereas a non-dimerizing
control L-selectin-specific mAb did not augment capture or rolling
(Fig. 1A). Cross-linking of the dimerizing mAb with a
secondary antibody did not further enhance L-selectin adhesiveness over
that induced by optimal levels of dimerizing mAb (data not shown).
Similar to pre-B cells, L-selectin expressed on other types of
leukocytes, including human neutrophils, peripheral blood
lymphocytes, and the T cell line Jurkat, also responded to the
dimerizing mAb by a similar augmentation of capture and rolling on
PSGL-1 as well as on other ligands including GlyCAM-1 and PNAd (data
not shown). Dissection of the augmenting effects of the dimerizing mAb
revealed that both the ability of L-selectin-expressing cells to
initiate tethers to high density PSGL-1 (110 sites/µm2)
and the conversion of these initial tethers into subsequent rolling
were enhanced by L-selectin dimerization (Fig. 1, A and B). L-selectin dimerization also significantly increased the
number of cells accumulated on a PSGL-1-coated substrate and the
smoothness of their rolling, concomitantly with a reduction in mean
rolling velocities (Fig. 1C). In contrast, L-selectin
dimerization did not reduce the shear threshold required for
lymphocytes to initiate L-selectin-mediated rolling on PSGL-1 (Fig. 1,
B and C). Below 0.75 dyn/cm2 neither
control mAb-treated transfectants nor cells treated with the dimerizing
mAb could roll on PSGL-1, although they could still transiently tether
to the ligand (Fig. 1C, inset).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Dimerization of L-selectin increases the
stability of rolling adhesions on PSGL-1. A, effect of
a dimerizing L-selectin mAb on accumulation at 1 dyn/cm2 of
rolling 300.19 murine pre-B cells transfected with human L-selectin on
purified PSGL-1 coated at 110 sites/µm2. Cells were
either left intact or pretreated with control or dimerizing
L-selectin-specific mAbs (LAM 1-101 and 1-118, respectively).
B, frequency of transient tethering and stable tethering
(rolling) of L-selectin transfectants pretreated with either
dimerizing mAb or control mAb at 1 dyn/cm2 on the same
PSGL-1-coated substrate tested in A. Values are the
mean ± range of two test fields. *, p < 0.0015 compared with control-mAb treated cells using a paired two-tailed
student's t test. C, accumulation of rolling
cells expressing comparable levels of either L-selectin (WT)
or EGF-domain mutant (LPL) on PSGL-1 (110 sites/µm2) under continuously incremented shear stresses.
L-selectin transfectants were pretreated with either dimerizing or
control mAb. Categories of rolling (smooth or
jerky) are shown as fractions of the cells accumulated on
the substrate at each shear stress. Cells were allowed to settle onto
the substrate for 30 s and then were subjected every 5 s to
the indicated stepwise increments of shear stress. The number of cells
remaining adherent in the field of view at each shear stress was
determined by computerized analysis. At each indicated shear stress,
the mean velocity of smoothly rolling cells (with a mean velocity <100
µm/sec) is indicated on top of bars. Inset, frequency of
tethering and rolling mediated by cells expressing LPL mutant or WT
L-selectin pretreated with dimerizing or control mAb at low shear
stress of 0.5 dyn/cm2 on the PSGL-1-coated substrate tested
in C. Data shown in A-C are representative of
five independent experiments.
|
|
An EGF domain mutant of L-selectin, termed LPL, derived by a
substitution of the L-selectin EGF domain with the homologous domain
from P-selectin, although not altering the overall length of the
mutated L-selectin, has been recently demonstrated by us to exhibit
enhanced recognition of immobilized ligands under shear flow, even in a
cell-free state (15). Remarkably, LPL expressed on 300.19 pre-B cells
exhibited far superior rolling activity versus that of
dimerized L-selectin (Fig. 1C). The LPL-transfected pre-B
cells exhibited much higher resistance to detachment by elevated shear
stresses than dimerized L-selectin and dramatically reduced rolling
velocities compared with cells treated with the L-selectin dimerizing
mAb (Fig. 1C). Furthermore, although L-selectin dimerization
did not reduce the threshold shear for rolling, the EGF domain
substitution lowered that shear threshold (Fig. 1C and
inset). These results indicate that the EGF domain mutation of L-selectin induces more robust augmentation of cell capture and
rolling than L-selectin dimerization. The data also suggest that the
dependence of the selectin adhesion on a shear stress threshold is not
altered by its dimerization state but, rather, by alteration of
intrinsic kinetic properties of selectin binding to immobilized ligand
(15).
Ligand Density and Spacing Dictates the Extent of Adhesion
Augmented by L-selectin Dimerization--
L-selectin dimerization is
expected to augment avidity only to properly clustered ligand. Indeed,
dimerization of L-selectin increased rates of cell capture and the
extent of initial tethering followed by rolling on high densities of
L-selectin ligands more than on low densities of coated ligands (Fig.
2A). Given that PSGL-1 is
dimeric and that GlyCAM-1 is decorated with multiple L-selectin-binding
carbohydrates (11), dimerization of L-selectin on the leukocyte surface
should augment its avidity to these ligands at any site density if
individual ligand moieties on these scaffolds are properly spaced.
However, below a critical value of coating density, the augmented
tethering induced by dimerization was abrogated on both PSGL-1 and on
GlyCAM-1 (Fig. 2A). Similar dependence of dimerization-enhanced L-selectin avidity on critical site density and
proper spacing of ligand was also observed with a PSGL-1-derived glycopeptide corresponding to the first 19 residues of PSGL-1, which
contains the major P- and L-selectin recognition sequences of native
PSGL-1 (Fig. 2B). This suggests that only above this density
can the peptide, anchored to the substrate via avidin, form effectively
spaced dimers recognized by mAb-dimerized L-selectin. Interestingly,
the coating density below which L-selectin dimerization no longer
augmented tether formation was significantly lower for GlyCAM-1 than
for PSGL-1 (Fig. 2A). This suggested a higher proportion of
properly spaced L-selectin-binding moieties on GlyCAM-1 than on PSGL-1
coated at similar protein scaffold densities. In support of this
possibility, GlyCAM-1 mediated more frequent rolling than PSGL-1 (Fig.
2A), and the velocities of rolling mediated by GlyCAM-1 were
far lower than rolling mediated on equivalent site densities of PSGL-1
(data not shown). Thus, although multivalent, when coated at 1 and 5 sites/µm2 on the test substrates, L-selectin-binding
moieties on the GlyCAM-1 and PSGL-1 scaffolds, respectively, could be
spaced too far to form dimers that could be recognized by dimerized
L-selectin on tethered lymphocytes. Consistent with this assumption,
L-selectin dimerization augmented L-selectin-mediated B cell tethering
to immobilized mAb directed against the lectin domain of the selectin only above a critical mAb coating density (Fig. 2C). Because
the mAb binds L-selectin at much higher affinity than natural
L-selectin glycoprotein (11, 15), these results indicate that
L-selectin dimerization enhances L-selectin-mediated adhesion to a
properly clustered ligand irrespective of its binding affinity to
L-selectin. In contrast and consistent with its inherently higher
adhesiveness, the EGF domain L-selectin mutant, LPL, readily formed
tethers even to diluted ligands at up to 10-20-fold higher frequencies than native L-selectin (Fig. 2A). Notably, the extent of
tether enhancement introduced by the EGF domain substitution was
similar on both GlyCAM-1 and PSGL-1, excluding the possibility that a specific association between the P-selectin-derived EGF domain with a
specific region on PSGL-1 accounted for the enhanced adhesiveness of
LPL to PSGL-1. Indeed, the mutant also interacted much more readily
than native L-selectin with the anti L-selectin mAb (Fig. 2C, inset, and data not shown). Thus, LPL retains
an inherent capacity to form functional tethers on any ligand tested
independent of its structure, density, or binding affinity to
L-selectin.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
Tethering of L-selectin-expressing cells
pretreated with dimerizing mAb to PSGL-1 and GlyCAM-1 coated at
different densities. A, tethering frequencies of WT
L-selectin-expressing pre-B cells pretreated with dimerizing or control
mAb on substrates coated with different densities of PSGL-1 or
GlyCAM-1. Net tethering frequency at each ligand density was derived by
subtracting background tethering measured in the presence of 5 mM EGTA. For comparison, net tethering of pre-B cells
expressing the EGF domain mutant (LPL) is shown at the lowest ligand
density range. Values are the mean ± range of two fields. At
ligand densities, where tethered cells established persistent rolling,
the fraction of these cells within initially tethered cells is
indicated in parenthesis. B, tethering frequency
of L-selectin-expressing cells pretreated with either dimerizing or
control mAb to substrate coated at different site densities of sulfated
sLex-bearing glycopeptide derived of the N' terminus
of PSGL-1. The peptide coated onto the surface via an avidin anchor as
described in "Experimental Procedures." For comparison, tethering
and rolling of pre-B cells expressing the LPL mutant is shown.
C, tethering frequency (transient or followed by immediate
arrest) of WT L-selectin-expressing cells pretreated with either
dimerizing or control mAb to substrates coated at different site
densities of the anti-L-selectin mAb, DREG-200. Neither the control nor
dimerizing L-selectin-specific mAbs interfered with DREG-200 binding to
L-selectin (data not shown). Inset, frequency of tethers
initiated by cells expressing the LPL mutant on low density DREG-200.
All measurements were performed at a shear stress of 1 dyn/cm2. Data in A-C are representative of
three experiments.
|
|
Inspite of augmenting L-selectin adhesion to different ligands,
L-selectin dimerization failed to augment L-selectin adhesiveness to a
non glycoprotein ligand, fucoidin, a multivalent polysaccharide that
consists of closely spaced L-selectin-binding sulfated carbohydrates (Fig. 3). Similar observations (data not
shown) were also found on substrates coated with another highly
clustered carbohydrate ligand, a sLex-decorated
neoglycolipid (16). Nevertheless and consistent with its higher
inherent adhesiveness, LPL-expressing cells tethered and rolled at
higher efficiencies than L-selectin on fucoidin (Ref. 15 and Fig. 3).
Thus, although dimerization of L-selectin augments its adhesiveness
only to properly clustered ligands, hyperclustering of ligand as in the
case of fucoidin masks the proadhesive effects of L-selectin
dimerization. The EGF domain substitution of L-selectin, in contrast,
augments the selectin adhesiveness even to this highly clustered
ligand, consistent with an intrinsically higher adhesive capacity of
the mutant to any ligand tested irrespective of its spacing on the
substrate.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Dimerization of L-selectin does not augment
lymphocyte adhesion to the polysaccharide ligand, fucoidin.
Frequencies of tethering and rolling mediated by WT
L-selectin-expressing cells pretreated with either dimerizing mAb or
control mAb, interacting with different densities of immobilized
fucoidin at a shear stress of 1 dyn/cm2 are shown. For
comparison, tethering and rolling of cells expressing the EGF-domain
mutant (LPL) was tested on identical fucoidin substrates.
All tethers could be blocked in the presence of the lectin
function-blocking mAb, DREG-200. Results are mean ± range of two
test fields. A representative experiment of four is shown.
|
|
The EGF Domain Mutant Responds to Dimerization at Much Lower PSGL-1
Densities than L-selectin--
The increased intrinsic reactivity of
the LPL mutant toward surface-immobilized L-selectin ligands could
result in loss of the mutant's responsiveness to dimerization.
Therefore, we next tested the effect of the dimerizing mAb on
LPL-mediated tethering to PSGL-1. mAb-induced dimerization of LPL was
found to augment tethering to low density PSGL-1 (Fig.
4A), indicating that the EGF
domain selectin mutant did respond to dimerization. Reminiscent of
L-selectin, mAb-induced dimerization of LPL augmented its tethering capacity to PSGL-1 proportionally to PSGL-1 density, and below a
critical PSGL-1 density dimerization no longer augmented tethering (Fig. 4A and data not shown). Strikingly, however, the
responsiveness of the mutant to the dimerizing mAb was retained at
PSGL-1 densities 10-20-fold lower than those required for dimerization
of L-selectin to augment tether formation (Fig. 4A
versus Fig. 2A). Thus, the EGF-domain mutant not
only tethered to individual PSGL-1 scaffolds at much higher efficiency
than L-selectin (Figs. 1, C and C inset and 2,
A and B) but appeared to recognize, upon
dimerization, functional ligands on PSGL-1 not recognized by dimerized
L-selectin. We therefore speculated that LPL might recognize closely
spaced L-selectin-binding carbohydrates on the PSGL-1 scaffold that are not recognized by native L-selectin. The high affinity P-selectin and
L-selectin-binding moiety on PSGL-1, comprised of an
N'-sulfotyrosine motif, necessary for the glycoprotein to
support rolling of P- or L-selectin-expressing cells (35, 36). However,
PSGL-1 is also decorated with multiple sLex moieties,
potential low affinity ligands for E-selectin and L-selectin (29, 37,
38). mAb blocking of the N' sulfotyrosine motif on PSGL-1 indeed
abolished L-selectin-mediated tethering to PSGL-1 but, nevertheless,
retained significant selectin-dependent tethering activity
of LPL (Fig. 4B). Furthermore, the LPL mutant could
efficiently form cellular tethers to a nonsulfated
sLex-decorated PSGL-1-derived peptide, whereas L-selectin
failed to form detectable tethers to this low affinity ligand (Fig.
4C). Thus, LPL appears to recognize multiple
sLex moieties on the PSGL-1 scaffold, which are not
recognized by native L-selectin under shear flow conditions. The
effective sLex density recognized by the LPL mutant on each
PSGL-1 scaffold is therefore higher than the density of the N'
sulfotyrosine motif recognized by L-selectin, rendering LPL more
responsive to dimerization than native L-selectin.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
The EGF-domain mutant recognizes non-sulfated
PSGL-1 moieties and responds to dimerization at lower PSGL-1 densities
than L-selectin. A, frequency of transient tethering
mediated by LPL mutant-expressing cells pretreated with either
dimerizing or control mAb on different site densities of PSGL-1 at
shear stress of 1 dyn/cm2. Results are shown as mean ± range of two test fields. B, residual cell tethering
activity of PSGL-1 preblocked with mAb directed to the sulfotyrosine
motif on the N' terminus of PSGL-1. Tethering frequency of cells
expressing either LPL mutant or WT L-selectin interacting with intact
or mAb-blocked PSGL-1 is shown. The majority of tethers were eliminated
in the presence of soluble fucoidin. Results are mean ± range of
two test fields. C, frequency of tethering mediated by cells
expressing either LPL mutant or WT L-selectin to immobilized
nonsulfated PSGL-1-derived N' terminal peptide bearing
sLex glycans. Data in A-C are representative of
three experiments.
|
|
Dimerization Augments L-selectin and LPL Tether Formation without
Altering Tether Lifetime--
Displacement motions of leukocytes
rolling on glycoprotein selectin ligands are comprised of discrete
steps separated by transient reversible pauses with characteristic
duration, reflective of bond stability at microvillar contact zones
(15, 16, 39). Notably, the duration of these tethers becomes
progressively shorter with reduced bond number within each tether (39)
and thus can serve as an indicator of L-selectin avidity. To gain
further insights into a possible modulation of tether duration rather
than formation by L-selectin dimerization, the microkinetics of rolling
motions on different low densities of PSGL-1 was next analyzed at high temporal resolution (Fig. 5). Such
measurements demonstrated that L-selectin dimerization did not prolong
the dissociation rate constant of L-selectin tethers to PSGL-1, even at
high PSGL-1 density (Fig. 5A). The duration of the vast
majority of tethers mediated by both control mAb-treated and dimerized
L-selectin could be fit into an homogenous group with a single first
order dissociation rate constant, independent of PSGL-1 density (Fig. 5, A and B). Thus, the high temporal resolution
analysis confirmed that the sole effect of L-selectin dimerization on
quantal adhesive tethers is an enhancement of tether formation rate on
properly clustered PSGL-1 (Fig. 5A). Furthermore, when
PSGL-1 density was too low to allow dimerization-induced enhancement of
tether formation, no effect on the duration of tethers could be
detected (Fig. 5C). Thus, neither the formation nor the
stability of L-selectin tethers were modulated by L-selectin
dimerization when the ligand density approached a critical density
value (
7 sites/µm2). Similar to its effects on
L-selectin, the dimerizing mAb augmented LPL mutant-mediated tether
formation without altering tether duration (Fig.
6A). Thus, dimerization of
both L-selectin and the LPL mutant resulted in augmented tethering, but
conserved duration of quantal adhesive tethers. Notably, at low PSGL-1
site densities that supported equivalent amount of tethers of either
L-selectin or LPL, i.e. 7 and 0.3 sites/µm2,
respectively, the dissociation rate constant of the majority of LPL
mutant-mediated tethers was comparable with that measured for
L-selectin tethers (Fig. 6B versus Fig.
5B). These results were consistent with previous kinetic
measurements of dissociation of transient tethers of LPL from GlyCAM-1,
which revealed that EGF domain substitution augments tether formation
of L-selectin without altering the kinetic stability of tethers (15).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of dimerization on tether formation
and dissociation from low density PSGL-1 coated substrates.
Dissociation kinetics of tethers mediated by WT L-selectin-expressing
cells pretreated with either control or dimerizing mAb and perfused at
a shear stress of 1 dyn/cm2 over PSGL-1 coated at 30 sites/µm2 (A) or 7 sites/µm2
(B). Cells were recorded at 500 frames/s. The
koff values were determined from the slope of
the natural log of number of tethers plotted versus the
duration of each tether. Tethers 0.004 s were not considered adhesive
and were excluded from analysis. Data points that fit a first order
dissociation curve (open symbols) are connected by a
straight line with a slope equaling koff. Data
points of L-selectin-mediated tethers that did not fit the first order
dissociation approximation are indicated by filled symbols.
These slower dissociating tethers are connected by a second line
yielding a second koff value (A).
The fraction of each group of tethers of the total tethers is
indicated. At low density ligand (B, C), these
events were too rare to yield a second koff
value. The mean pause number per cells tethered to the substrate is
also indicated. C, dissociation kinetics of tethers formed
by control or dimerizing mAb-treated L-selectin-expressing cells
interacting with sulfated PSGL-1-derived glycopeptide at 1 dyn/cm2. r, coefficient of correlation. Data are
representative of three experiments.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of dimerization of the EGF-domain
mutant on tether formation and dissociation from low density
PSGL-1-coated substrates. Dissociation kinetics of tethers
mediated by LPL mutant expressing cells pretreated with either
dimerizing or control mAb on PSGL-1 substrates coated at 1 sites/µm2 (A) or 0.3 sites/µm2
(B). The various koff values were
determined at 1 dyn/cm2 as described in Fig. 5. Data are
representative of three experiments.
|
|
Shear Stress Reduces the Ligand Density Threshold Required for
Tether Enhancement by L-selectin Dimerization--
The cumulative
results of this study suggested that to translate L-selectin
dimerization into augmented tether formation, L- selectin must
recognize properly spaced L-selectin-binding moieties on its
counterreceptor scaffolds. Shear flow has been proposed to increase the
bond number between L-selectin and ligand at local microvillar contacts
based on the observation that tethers formed at elevated shear stresses
dissociated with slower kinetics than tethers formed at low shear
stresses (39). To test the effect of shear stress on the responsiveness
of L-selectin to mAb-induced dimerization, we compared the frequency of
tethering to PSGL-1 present at a density too low for mAb-induced
dimerization to augment tether formation. Strikingly, the frequency of
L-selectin tethering to low density PSGL-1 was rendered more sensitive
to L-selectin dimerization when measured at high shear stress (1.75 dyn/cm2) as compared with lower shear stress (1 dyn/cm2) (Fig. 7, PSGL-1 2 or
22 sites/µm2). Conversely, at high PSGL-1 density, where
the frequency of L-selectin tethering at 1-1.75 dyn/cm2
was sensitive to L-selectin dimerization, L-selectin dimerization failed to augment any tether formation at a shear stress of 0.5 dyn/cm2 (Fig. 7, PSGL-1, 22 sites/µm2).
Similar increased sensitivity of tethering to L-selectin dimerization at increased shear stresses was observed on low density GlyCAM-1 as
well as on the sulfated PSGL-1-derived glycopeptide (data not shown).
Shear flow proportionally increases the velocity of flowing cells over
the adhesive surface and thereby may enhance bond formation via
cellular transport (40). To rule out the possibility that increased
sensitivity of tether formation to L-selectin dimerization may be
transport-dependent, the rate of transient tethering under each shear stress condition was divided by the corresponding shear rate
to derive the transport-independent frequency of cellular tethers (Fig.
7B). Indeed, even after such normalization of tether frequency, the sensitivity of tether formation to L-selectin
dimerization was significantly higher at elevated shear stresses, in
particular at lower ligand densities. This is a first demonstration
that the effective availability of immobilized L-selectin ligands, recognized by dimerized L-selectin, is increased by elevated shear stress. This increase appears independent of the transport rate of
L-selectin expressing cells over the ligand-coated substrate.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Dimerization-enhanced L-selectin tethering is
shear force dependent. A, frequency of tethering
mediated by WT L-selectin-expressing cells pretreated with either
dimerizing mAb or control mAb interacting with the indicated densities
of immobilized PSGL-1. Tethering frequencies were measured at different
shear stresses in separate experiments. Data are mean ± S.E. of
four fields of view. *, p < 0.01 and **,
p < 0.00015, are compared with control-mAb-treated
cells. Tethers were effectively blocked in the presence of 5 mM EGTA (right panel) or saturating levels of
soluble fucoidin (not shown). Results are representative of three
independent experiments. B, same data as in A,
but the frequency results in A were divided by the shear
rate to derive the transport-independent frequency of cellular tethers.
Data are representative of four experiments.
|
|
 |
DISCUSSION |
In the present study, the role of L-selectin dimerization in
conferring selectin adhesiveness to different selectin-binding scaffolds was investigated under various flow conditions. Our results
provide the first evidence that L-selectin clustering up-regulates
rolling adhesions as a result of an increased rate of tether formation
to ligand clusters under shear flow. Notably, dimerization augments
L-selectin avidity solely to properly spaced ligand moieties. In other
cases, i.e. below a critical density of selectin
counterreceptor like PSGL-1 or GlyCAM-1 or when ligand moieties are
highly clustered L-selectin dimerization does not augment adhesion.
L-selectin dimerization can therefore serve as a readout for the
presence of properly spaced ligand on the countersurface. Several other
important conclusions have been derived. 1) Dimerization of L-selectin
alters different dynamic properties of tethers than those altered by
P-selectin dimerization even when the same scaffold protein,
i.e. PSGL-1, serves as the exclusive ligand for the two
selectins (10). Whereas L-selectin dimerization enhances tether
formation without altering tether lifetime, P-selectin dimerization
prolongs tether lifetime and increases the mechanical strength of
P-selectin tethers to PSGL-1 but does not enhance tether formation
rates (10). In fact, none of the structural or clustering modifications
of L-selectin investigated here were found to alter the apparent
koff of L-selectin-mediated tethers measured at
different densities or shear stresses. Rather, these modifications
enhanced only the rate of tether formation. 2) In contrast to
dimerization, EGF domain substitution enhances tether formation by
L-selectin and does so regardless of the state of ligand density or
spacing and independent of the shear stress tested.
One of the most intriguing observations in this study is that
dimerization enhanced L-selectin avidity to ligand only under proper
shear stress conditions. Thus, even when the ligand density was high
enough to be recognized by dimerized L-selectin (Fig. 7), reduced shear
stress eliminated the contribution of dimerization to tether formation.
Conversely, when ligand density was low, such that dimerization of
L-selectin did not contribute to tethering, elevation of shear stress
introduced an augmenting effect for L-selectin dimerization (Fig. 7).
Because dimerization of L-selectin augmented tethering only to properly
clustered ligand, this result suggests that dimers of L-selectin:ligand
pairs are more readily formed at elevated physiological shear stresses.
As mAb-induced L-selectin dimers may mimic naturally occurring
L-selectin dimers on the surface of tethered leukocytes, this result
also suggests that such natural L-selectin dimers could form dimers
with physiological selectin counterreceptors more readily at elevated
shear stresses than at subphysiological stresses.
How can enhanced shear stress increase the productive
formation of tethers between dimerized L-selectin and ligand clusters? Two nonmutually exclusive mechanisms have been proposed to explain the
shear threshold requirement of L-selectin adhesion. The first suggests
that cellular transport along the adhesive substrate, which is
increased with applied shear, may increase the forward rate of binding
between tethered reactants on interacting countersurfaces (40, 41).
However, if only transport was involved, then at low density ligand,
the local density of ligand clusters as seen by the dimerized
L-selectin would remain constant regardless of the cell transport and
the global contact area formed between the leukocyte and the substrate
(40). Indeed, even after correcting for contribution of cellular
transport relative to the substrate (Fig. 7B), the fold
increase of L-selectin tethering frequency induced by L-selectin
dimerization steadily increased at elevated shear stress (Fig.
7B), suggesting that enhanced cellular transport could not
account for the increased tethering capacity of dimerized L-selectin.
The second mechanism proposed for the shear requirement of L-selectin
suggests that shear stress directly activates L-selectin recognition of
immobilized ligand. Because PSGL-1 was immobilized on the substrate and
the effect of shear stress on dimerization-augmented tethering to
PSGL-1 is fully reversible upon shear reduction (data not shown), it is
unlikely that elevated shear stresses could have redistributed PSGL-1
to become more favorably recognized by L-selectin dimers. Shear stress
could have, however, directly increased intrinsic L-selectin
recognition of ligand, as it was reported to enhance the adhesive
capacity of both cell-based and cell-free L-selectin toward multiple
types of ligands (42, 43). However, shear stress failed to increase
L-selectin tethering to L-selectin lectin-specific mAbs or to an
artificial highly clustered ligand, such as fucoidin (15, 44). It
therefore appears that shear stress facilitates the recognition by
L-selectin of native low affinity carbohydrate ligand moieties. One way
to achieve this facilitated recognition of ligand could involve a shear-dependent reduction in repulsive barriers between the
negatively charged sialylated and sulfated L-selectin ligands and the
L-selectin-bearing cell surface. Consistent with such a possibility,
CD43, a highly sialylated mucin-like glycoprotein, has been reported to
exert anti-adhesive effects on lymphocyte L-selectin adhesiveness under physiological shear flow (45). Shear flow may also generate local
torque forces (46) impinging tethered leukocytes onto the substrate and
thereby enhancing encounters between L-selectin dimers and properly
spaced selectin ligand moieties on the countersurface.
L-selectin dimerization was found to selectively augment
tether formation without affecting tether duration. Transient
L-selectin tethers, quantal adhesive units formed to distinct
L-selectin counterreceptors including PSGL-1, GlyCAM-1, and PNAd, share
similar lifetimes even though these scaffolds have entirely different composition and spatial distribution of L-selectin carbohydrate units.2 Interestingly,
increased bond density, although dramatically prolonging tether
lifetime of P-selectin (7, 10), results in only modest changes of
L-selectin tether lifetime (8, 42). These observations collectively
suggest that bond clustering at singular contact sites contributes
relatively little to L-selectin tether stabilization as opposed to
P-selectin tether stabilization. High temporal resolution analysis of
L-selectin tethers to PSGL-1, performed here for the first time,
further confirmed that kinetic stability of L-selectin tethers to
highly diluted ligands is practically insensitive to selectin
dimerization, although it increases tether formation to properly spaced
ligand moieties. Thus, increased rebinding within a cluster of
L-selectin occupied by properly spaced ligands increases tether
formation, but once formed, the tether fails to undergo further
stabilization. In contrast, stabilization of quantal L-selectin tethers
is highly sensitive to perturbation of cytoskeletal associations of
L-selectin, and dimerization does not rescue this perturbation (16). It
is possible that rebinding of L-selectin to the same ligand, from which
it has dissociated, depends on cytoskeletal anchorage and restricted
mobility of the selectin (16). This autonomous rebinding increases
tether stabilization, whereas rebinding of L-selectin within a cluster
of bonds, facilitated by selectin dimerization, may increase tether
formation. The distinct kinetic outcomes of cytoskeletal anchorage of
L-selectin versus selectin dimerization raise the
interesting possibility that distinct selectin rebinding events may
involve different time scales that contribute to either tether
formation or stabilization.
Oligomerization of L-selectin (11) or of its ligands (47,
48) has been shown to elevate L-selectin avidity by several orders of
magnitude in cell-free shear-less systems, suggesting that rebinding of
L-selectin at closely spaced ligand matrices can indeed compensate for
the extremely low affinity with which it binds to monovalent ligand
(11). Although the physiological occurrence and implications of
L-selectin dimers on leukocyte microvilli are still obscure (17),
L-selectin clustering could be up-regulated during inflammatory
processes. Interestingly, exposure of human peripheral blood
lymphocytes or murine pre-B transfectants to fever-range hyperthermia
markedly increases L-selectin clustering and association with the
cytoskeleton with concomitantly enhanced L-selectin-mediated adhesion
(49). Our results predict that such clustering would bear physiological
outcome only if the L-selectin ligand at the endothelial target site is
also properly clustered. The site density and distribution of
glycoprotein ligands, i.e. their homodimerization states,
the spacing between their ligand decorated O-glycans, and
possibly the dimerization of adjacent carbohydrate ligands on
biantennary O-glycans (21, 32), could each affect the degree
by which L-selectin dimerization on leukocytes would contribute to
capture and rolling adhesions under various shear flow conditions. In
conclusion, our studies suggest that L-selectin:ligand clusters
facilitate selectin tether formation and consequently cell capture and
rolling under physiological shear forces. The resolution of how spacing
between selectin molecules and their particular counterreceptors
contribute to selectin avidity at subsecond contact sites under shear
flow should unravel the molecular basis of selectin function in
distinct vascular beds and dynamic environments. Elucidation of this
standing question will help in the future design of specific selectin
or ligand antagonists functional at diverse pathological contexts
implicating L-selectin.
 |
ACKNOWLEDGEMENTS |
We warmly thank Dr. R. P. McEver for
generously providing PSGL-1 used throughout the study. We also thank
Drs. S. D. Rosen and T. K. Kishimoto for gifts of reagents. We also
thank Dr. S. W. Feigelson for helpful discussions and Dr. S. Schwarzbaum for editorial assistance.
 |
FOOTNOTES |
*
This work was supported in part by the United States Israel
Binational Science Foundation (to R. A. and G. S. K) and by the Israel Science Foundation founded by the Israel Academy of Sciences and
Humanities (to R. A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by the Emmy-Noether-Programme of the German Science Foundation.
§§
Recipient of National Institutes of Health Grant 1R24HL64381.
¶¶
Incumbent of The Tauro Career Development Chair in
Biomedical Research. To whom correspondence should be addressed: Dept. of Immunology, Weizmann Inst. of Science, Rehovot, 76100 Israel; Tel.:
972-8-9342482; Fax: 972-8-9344141; Email:
ronalon@wicc.weizmann.ac.il.
Published, JBC Papers in Press, March 20, 2002, DOI 10.1074/jbc.M201999200
2
O. Dwir and R. Alon, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
EGF, epidermal
growth factor;
mAb, monoclonal antibody;
SCR, short consensus repeats;
PBS, phosphate-buffered saline;
HSA, human serum albumin;
sLex, sialyl Lewisx;
PNAd, peripheral node
addressin;
GlyCAM-1, glycoprotein cell adhesion molecule 1;
PSGL-1, P-selectin glycoprotein ligand;
WT, wild type.
 |
REFERENCES |
| 1.
|
Lawrence, M. B.,
and Springer, T. A.
(1991)
Cell
65,
859-873[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Kansas, G. S.
(1996)
Blood
88,
3259-3287[Free Full Text]
|
| 3.
|
Miller, J.,
Knorr, R.,
Ferrone, M.,
Houdei, R.,
Carron, C. P.,
and Dustin, M. L.
(1995)
J. Exp. Med.
182,
1231-1241[Abstract/Free Full Text]
|
| 4.
|
Chang, K. C.,
and Hammer, D. A.
(2000)
Biophys. J.
79,
1891-1902[Abstract/Free Full Text]
|
| 5.
|
Chang, K. C.,
Tees, D. F.,
and Hammer, D. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
11262-11267[Abstract/Free Full Text]
|
| 6.
|
Evans, E.,
Leung, A.,
Hammer, D.,
and Simon, S.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
3784-3789[Abstract/Free Full Text]
|
| 7.
|
Alon, R.,
Hammer, D. A.,
and Springer, T. A.
(1995)
Nature
374,
539-542[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Alon, R.,
Chen, S.,
Puri, K. D.,
Finger, E. B.,
and Springer, T. A.
(1997)
J. Cell Biol.
138,
1169-1180[Abstract/Free Full Text]
|
| 9.
|
Ramachandran, V.,
Nollert, M. U.,
Qiu, H.,
Liu, W. J.,
Cummings, R. D.,
Zhu, C.,
and McEver, R. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13771-13776[Abstract/Free Full Text]
|
| 10.
|
Ramachandran, V.,
Yago, T.,
Epperson, T. K.,
Kobzdej, M. M.,
Nollert, M. U.,
Cummings, R. D.,
Zhu, C.,
and McEver, R. P.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
10166-10171[Abstract/Free Full Text]
|
| 11.
|
Nicholson, M. W.,
Barclay, A. N.,
Singer, M. S.,
Rosen, S. D.,
and van der Merwe, P. A.
(1998)
J. Biol. Chem.
273,
763-770[Abstract/Free Full Text]
|
| 12.
|
van der Merwe, P. A.,
Barclay, A. N.,
Mason, D. W.,
Davies, E. A.,
Morgan, B. P.,
Tone, M.,
Krishnam, A. K.,
Ianelli, C.,
and Davis, S. J.
(1994)
Biochemistry
33,
10149-10160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Chen, S.,
Alon, R.,
Fuhlbrigge, R. C.,
and Springer, T. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3172-3177[Abstract/Free Full Text]
|
| 14.
|
Puri, K. D.,
Chen, S.,
and Springer, T. A.
(1998)
Nature
392,
930-933[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Dwir, O.,
Kansas, G. S.,
and Alon, R.
(2000)
J. Biol. Chem.
275,
18682-18691[Abstract/Free Full Text]
|
| 16.
|
Dwir, O.,
Kansas, G. S.,
and Alon, R.
(2001)
J. Cell Biol.
155,
145-156[Abstract/Free Full Text]
|
| 17.
|
Li, X.,
Steeber, D. A.,
Tang, M. L. K.,
Farrar, M. A.,
Perlmutter, R. M.,
and Tedder, T. F.
(1998)
J. Exp. Med.
188,
1385-1390[Abstract/Free Full Text]
|
| 18.
|
Setiadi, H.,
Sedgewick, G.,
Erlandsen, S. L.,
and McEver, R. P.
(1998)
J. Cell Biol.
142,
859-871[Abstract/Free Full Text]
|
| 19.
|
Snapp, K. R.,
Craig, R.,
Herron, M.,
Nelson, R. D.,
Stoolman, L. M.,
and Kansas, G. S.
(1998)
J. Cell Biol.
142,
263-270[Abstract/Free Full Text]
|
| 20.
|
Rosen, S. D.,
and Bertozzic, R.
(1996)
Curr. Biol.
6,
261-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Yeh, J. C.,
Hiraoka, N.,
Petryniak, B.,
Nakayama, J.,
Ellies, L. G.,
Rabuka, D.,
Hindsgaul, O.,
Marth, J. D.,
Lowe, J. B.,
and Fukuda, M.
(2001)
Cell
105,
957-969[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
von Andrian, U. H.,
Hasslen, S. R.,
Nelson, R. D.,
Erlandsen, S. L.,
and Butcher, E. C.
(1995)
Cell
82,
989-999[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
McEver, R. P.,
and Cummings, R. D.
(1997)
J. Clin. Invest.
100,
S97-S103[Medline]
[Order article via Infotrieve]
|
| 24.
|
McEver, R. P.,
and Cummings, R. D.
(1997)
J. Clin. Invest.
100,
485-491[Medline]
[Order article via Infotrieve]
|
| 25.
|
Somers, W. S.,
Tang, J.,
Shaw, G. D.,
and Camphausen, R. T.
(2000)
Cell
103,
467-479[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Kishimoto, T. K.,
Jutila, M. A.,
and Butcher, E. C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2244-2248[Abstract/Free Full Text]
|
| 27.
|
Steeber, D. A.,
Engel, P.,
Miller, A. S.,
Sheetz, M. P.,
and Tedder, T. F.
(1997)
J. Immunol.
159,
952-963[Abstract]
|
| 28.
|
Moore, K. L.,
Patel, K. D.,
Bruehl, R. E.,
Fungang, L.,
Johnson, D. L.,
Lichenstein, H. S.,
Cummings, R. D.,
Bainton, D. F.,
and McEver, R. P.
(1995)
J. Cell Biol.
128,
661-671[Abstract/Free Full Text]
|
| 29.
|
Moore, K. L.,
Eaton, S. F.,
Lyons, D. E.,
Lichenstein, H. S.,
Cummings, R. D.,
and McEver, R. P.
(1994)
J. Biol. Chem.
269,
23318-23327[Abstract/Free Full Text]
|
| 30.
| Lasky, L. A., Singer, M. S., Dowbenko, D., Imai, Y.,
Henzel, W., Fennie, C., Watson, S., and Rosen, S. D. (1992)
Cold Spring Harbor Symp. Quant. Biol. 259-269
|
| 31.
|
Marttila, A. T.,
Laitinen, O. H.,
Airenne, K. J.,
Kulik, T.,
Bayer, E. A.,
Wilchek, M.,
and Kulomaa, M. S.
(2000)
FEBS Lett.
467,
31-36[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Rosen, S. D.,
and Bertozzi, C. R.
(1994)
Curr. Opin. Cell Biol.
6,
663-673[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Kansas, G. S.,
Saunders, K. B.,
Ley, K.,
Zakrzewicz, A.,
Gibson, R. M.,
Furie, B. C.,
Furie, B.,
and Tedder, T. F.
(1994)
J. Cell Biol.
124,
609-618[Abstract/Free Full Text]
|
| 34.
|
Dwir, O.,
Shimron, F.,
Chen, C.,
Singer, M.,
Rosen, S. D.,
and Alon, R.
(1998)
Cell. Adhes. Commun.
6,
349-370[Medline]
[Order article via Infotrieve]
|
| 35.
|
Spertini, O.,
Cordey, A. S.,
Monai, N.,
Giuffre, L.,
and Schapira, M.
(1996)
J. Cell Biol.
135,
523-531[Abstract/Free Full Text]
|
| 36.
|
Tu, L.,
Chen, A.,
Delahunty, M. D.,
Moore, K. L.,
Watson, S. R.,
McEver, R. P.,
and Tedder, T. F.
(1996)
J. Immunol.
157,
3995-4004[Abstract]
|
| 37.
|
Goetz, D. J.,
Greif, D. M.,
Ding, H.,
Camphausen, R. T.,
Howes, S.,
Comess, K. M.,
Snapp, K. R.,
Kansas, G. S.,
and Luscinskas, F. W.
(1997)
J. Cell Biol.
137,
509-519[Abstract/Free Full Text]
|
| 38.
|
Li, F.,
Wilkins, P. P.,
Crawley, S.,
Weinstein, J.,
Cummings, R. D.,
and McEver, R. P.
(1996)
J. Biol. Chem.
271,
3255-3264[Abstract/Free Full Text]
|
| 39.
|
Chen, S.,
and Springer, T. A.
(1999)
J. Cell Biol.
144,
185-200[Abstract/Free Full Text]
|
| 40.
|
Chang, K. C.,
and Hammer, D. A.
(1999)
Biophys. J.
76,
1280-1292[Abstract/Free Full Text]
|
| 41.
|
Chen, S.,
and Springer, T. A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
950-955[Abstract/Free Full Text]
|
| 42.
|
Alon, R.,
Chen, S.,
Fuhlbrigge, R.,
Puri, K. D.,
and Springer, T. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11631-11636[Abstract/Free Full Text]
|
| 43.
|
Greenberg, A. W.,
Brunk, D. K.,
and Hammer, D. A.
(2000)
Biophys. J.
79,
2391-2402[Abstract/Free Full Text]
|
| 44.
|
Finger, E. B.,
Puri, K. D.,
Alon, R.,
Lawrence, M. B.,
von Andrian, U. H.,
and Springer, T. A.
(1996)
Nature
379,
266-269[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Stockton, B. M.,
Cheng, G.,
Manjunath, N.,
Ardman, B.,
and von Andrian, U. H.
(1998)
Immunity
8,
373-381[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Lawrence, M. B.,
Kansas, G. S.,
Kunkel, E. J.,
and Ley, K.
(1997)
J. Cell Biol.
136,
717-727[Abstract/Free Full Text]
|
| 47.
|
Seppo, A.,
Turunen, J. P.,
Penttila, L.,
Keane, A.,
Renkonen, O.,
and Renkonen, R.
(1996)
Glycobiology
6,
65-71[Abstract/Free Full Text]
|
| 48.
|
Toppila, S.,
Lauronen, J.,
Mattila, P.,
Turunen, J. P.,
Penttila, L.,
Paavonen, T.,
Renkonen, O.,
and Renkonen, R.
(1997)
Eur. J. Immunol.
27,
1360-1365[Medline]
[Order article via Infotrieve]
|
| 49.
|
Evans, S. S.,
Schleider, D. M.,
Bowman, L. A.,
Francis, M. L.,
Kansas, G. S.,
and Black, J. D.
(1999)
J. Immunol.
162,
3615-3624[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us